Fondazione Piemontese per la Ricerca sul Cancro

What Fondazione Piemontese per la Ricerca sul Cancro does

The Fondazione Allegra Agnelli per la Ricerca sul Cancro (formerly Fondazione Piemontese per la Ricerca sul Cancro) is an Italian non-profit foundation established in 1986 by the Agnelli family to fund cancer research and care. It operates INOC – Istituto Nazionale Oncologico Candiolo in Candiolo, Piedmont, which is the only Italian oncology center entirely built with private donor funds and serves as the first IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) in Piedmont and an OECI-accredited Comprehensive Cancer Centre since 2022. The institute employs 291 researchers across 40 laboratories and 577 healthcare operators, delivers over one million outpatient services per year, and runs 256 active experimental and clinical protocols, with research output evidenced by 16,000+ publication citations.

The foundation's core technology platform is the Biolife infrastructure, comprising Italy's largest living biobank at 3,000 sqm (tissues, plasma, DNA, blood, saliva, feces linked to clinical data), a Centro Organoidi for patient-derived 3D tumor modeling including microenvironment components, and a Centro di Omiche Avanzate for genomic and molecular analysis. Clinical operations are supported by a high-end technology park including Da Vinci SP robotic surgery systems (with the first single-port mastectomy performed in June 2024), two Tomotherapy units, latest-generation PET-CT, Spectral and forthcoming photon-counting CT, molecular pathology laboratories, and advanced angiography. The foundation reports that 0.87 euros of every euro raised is directed to institutional purposes and invested 18M+ EUR in research and care in 2024.

The business model is donation-driven with no commercial pricing: revenue streams include individual donations (regular, memorial, testamentary bequests), the Italian 5X1000 tax mechanism, corporate partnerships with major Italian brands (Lavazza, Intesa Sanpaolo, Nova Coop, Juventus FC, Torino FC, Lega Basket Serie A), banking foundations (Compagnia di San Paolo, Fondazione CRT), the Ricerca la Fortuna charity lottery, and a solidarity shop (Candiolo Shop). The foundation engages 286,934+ cumulative donors, runs 82 events annually, and has announced a 250 million euro investment plan through 2035 for the Biolife platform and research expansion.

Name

Fondazione Piemontese per la Ricerca sul Cancro

Legal name

Fondazione Allegra Agnelli per la Ricerca sul Cancro ETS

Website

https://fprc.it

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

11–50 employees

Short description

Established in 1986, the Fondazione Allegra Agnelli per la Ricerca sul Cancro funds and operates INOC, a Piedmont-based cancer research and treatment institute. It serves cancer patients through precision oncology, 256 active clinical protocols, and a planned 250M EUR Biolife infrastructure expansion through 2035.

Ownership category

akta.pro rank

Product category

Cancer Research and Oncology Healthcare

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Offices of Physicians (62111)

SIC

Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM), Medical Oncology (HLAKAFAB)

Keywords

• Cancer research
• Oncology treatment
• Medical research
• Nonprofit healthcare
• Clinical research

Headquarters

HQ city

Candiolo

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

1. Individual Donations: Regular donations, one-time gifts, and memorial donations from individuals supporting cancer research and care.
2. 5X1000 Tax Donation: Italian tax mechanism allowing taxpayers to direct 0.5% of their income tax to eligible non-profit organizations including foundations engaged in scientific research.
3. Testamentary Bequests: Legacy donations through wills and testamentary bequests.
4. Corporate Partnerships: Sponsorship and partnership contributions from businesses, with tax benefits for companies (deduction up to 10% of total income or up to 30,000 euros/2% of business income).
5. Charity Lotteries: Ricerca la Fortuna lottery with prizes funded by donations.
6. Solidarity Shop: Candiolo Shop selling solidarity products where purchases equate to donations.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

The Fondazione Piemontese per la Ricerca sul Cancro (also known as Fondazione Allegra Agnelli per la Ricerca sul Cancro) is a non-profit foundation established in 1986 that funds and supports cancer research and operates the INOC (Istituto Nazionale Oncologico Candiolo), a specialized oncology institute in Candiolo, near Turin, Italy. The foundation raises funds for cancer research, supports clinical care, and integrates research activities with hospital services for oncology patients.

Product overview

Fondazione Allegra Agnelli per la Ricerca sul Cancro operates as a cancer research foundation established in 1986, supporting INOC – Istituto Nazionale Oncologico Candiolo. The foundation's portfolio includes the main research institute (INOC), the Biolife research platform with Biobanca, Centro Organoidi, and Centro di omiche avanzate for precision oncology. Patient-facing services include Candiolo Cares (wellness programs), Candiolo News (information portal), Magazine Fondazione (publication), and Candiolo Shop (solidarity commerce). The institute provides care through 577 healthcare operators delivering over 1 million outpatient services annually.

Differentiator

Problem solved

Functional benefit

Brands

• INOC - Istituto Nazionale Oncologico Candiolo: The main research and care institute operated by the foundation, a national oncology institute and IRCCS (Scientific Institute for Hospitalization and Care).
• Candiolo Cares
• Life is Pink
• Life is Blu

Products and services

• Cancer Research Funding Funding and support for cancer research programs, including laboratory research, clinical trials, and translational research initiatives aimed at understanding and combating cancer. Targeted at the scientific and medical research community.
• Oncology Treatment Services (INOC) Specialized oncology diagnosis, treatment, and care services provided through the Istituto Nazionale Oncologico Candiolo (INOC). Targeted at cancer patients seeking advanced clinical care in Italy.
• Translational Research Programs Programs that bridge laboratory research findings with clinical applications, enabling the development of new oncology treatments and therapies. Targeted at researchers, clinicians, and patients.

Quantifiable outcome

• 291 researchers in 40 laboratories and research units
• +5 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

18 partnerships are on record, tiered core and minor.

• Lavazza GroupcoreGTM or Marketing PartnerCorporate partner supporting the foundation's cancer research and care activities through donations and sponsorship.
• Intesa SanpaolocoreGTM or Marketing PartnerMajor banking partner with initiatives such as 'Un Ace per la Ricerca' supporting cancer research; donated ecografo 3D to the institute.
• Nova CoopcoreGTM or Marketing PartnerRetail partner with ongoing campaigns including 'Una spesa contro il cancro' generating over 173,000 euros; donated over 158,000 euros.
• Juventus FCcoreGTM or Marketing PartnerSports partner supporting through events like 'Un derby per la ricerca' and 'Alley Oop per la Ricerca' charity dinner; TOH (Together or Help) initiative.
• Torino FCcoreGTM or Marketing PartnerSports partner collaborating with Juventus FC in derby events for cancer research fundraising.
• Banca Territori del MonvisominorGTM or Marketing PartnerCooperative bank organizing charity dinners such as the Beneficial Dinner on September 3rd supporting the foundation.
• Lega Basket Serie A (LBA)coreGTM or Marketing PartnerBasketball league partner with 'Una Tripla per Candiolo' initiative supporting cancer research.
• Life is PinkcoreGTM or Marketing PartnerCampaign dedicated to research on female cancers, including events, shopping nights, sports activities, and donations of medical equipment.
• Fiera del Peperone di CarmagnolacoreGTM or Marketing PartnerAnnual food fair serving as charity partner, with the 77th edition from August 28 to September 6, 2026.
• MITO SettembreMusicacoreGTM or Marketing PartnerMusic festival partnership with concerts and events at the institute and in the city.
• Salone Internazionale del Libro di TorinocoreGTM or Marketing PartnerMajor book fair partnership with Calcetto Letterario (literary football) and book-related fundraising activities.
• ArtissimacoreGTM or Marketing PartnerContemporary art fair partnership supporting cancer research.
• Torino Film FestivalcoreGTM or Marketing PartnerAnnual film festival partnership supporting the foundation's mission.
• Torino City MarathoncoreGTM or Marketing PartnerRunning event partnership with 'City Run' generating approximately 20,000 euros for research.
• StracandiolocoreGTM or Marketing PartnerFoundation's own running event with over 1,000 participants and 15,000 euros raised in 2026.
• Federazione Italiana RugbycoreGTM or Marketing PartnerRugby federation partnership for cancer prevention and research support.
• Jannik SinnercoreGTM or Marketing PartnerTennis champion supporting the foundation; participated in launch of new Biobank construction works.
• Regione PiemontecoreGTM or Marketing PartnerRegional government partner with President Alberto Cirio inaugurating new facilities and supporting initiatives.

Scale indicators14 records

Recent moves9 records

Expansion highlights5 records

Others

• Fondazione Telethon: Italian non-profit research foundation using the same community-led donation model (5X1000, individual giving, celebrity/sports partnerships); comparable for fundraising mechanism and Italian third-sector operating context.

Broad incumbents

• Vall d'Hebron Institute of Oncology (VHIO): Spanish translational oncology research center integrated with a leading university hospital; comparable as a European specialty oncology research/care institute with similar precision-oncology programs.
• Memorial Sloan Kettering Cancer Center: World-leading specialty oncology hospital and research institute; comparable as a globally recognized cancer center delivering high-volume outpatient services, clinical trials, and translational research.
• Gustave Roussy Institute: Leading European Comprehensive Cancer Centre in France; comparable as a flagship oncology specialty hospital and research center with OECI-level accreditation and precision-oncology programs.
• German Cancer Research Center (DKFZ): Germany's largest biomedical research institute focused on cancer; comparable as a publicly-funded European cancer research powerhouse against which INOC benchmarks research output and infrastructure scale.

Direct peers

• European Institute of Oncology (IEO) - Umberto Veronesi Foundation: Italian foundation supporting cancer research and prevention; directly comparable as a non-profit philanthropy backing oncology science with similar fundraising and awareness mechanisms.
• Fondazione IRCCS Istituto Nazionale dei Tumori (INT): Italy's leading public national cancer institute in Milan, IRCCS-designated; provides specialty oncology care and translational research, directly comparable to INOC's mission and patient-care scale.
• AIRC - Fondazione AIRC per la ricerca sul cancro: Italy's largest non-profit funder of cancer research, headquartered in Milan; comparable as a donation-driven foundation supporting cancer research with a similar revenue model (5X1000, individual and corporate donations) to FPRC.
• IFOM - FIRC Institute of Molecular Oncology: Italy-based non-profit molecular oncology research institute in Milan; comparable as an Italian cancer research organization competing for the same research talent, donor base, and competitive grant funding as INOC.
• Istituto Europeo di Oncologia (IEO): Major specialty cancer hospital and research center in Milan offering oncology treatment and clinical research; competes with INOC for Italian cancer patients, top researchers, and philanthropic funding.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/fprc_candiolo
• YouTubeyoutube.com/@fondazionecandiolo
• Facebookfacebook.com/fondazionecandiolo
• LinkedInlinkedin.com/company/fprc
• Instagraminstagram.com/fondazionecandiolo

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fondazione Piemontese per la Ricerca sul Cancro